CELV (Cellev8 Nutrition) ROC (Joel Greenblatt) %: -9,706.25% (As of Nov. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CELV Cellev8 Nutrition Inc CELV
30 GF Score
Price $0.05
View Full Analysis

What is Cellev8 Nutrition ROC (Joel Greenblatt) %?

Cellev8 Nutrition CELV +2.97% 30 ROC (Joel Greenblatt) % is -9,706.25% as of Nov. 2015. GuruFocus rates CELV with a GF Score™ of 30/100.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Cellev8 Nutrition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2015 was -9,706.25%.

The historical rank and industry rank for Cellev8 Nutrition's ROC (Joel Greenblatt) % or its related term are showing as below:

CELV's ROC (Joel Greenblatt) % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 11.99
* Ranked among companies with meaningful ROC (Joel Greenblatt) % only.

Cellev8 Nutrition's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Cellev8 Nutrition  (OTCPK:CELV) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Cellev8 Nutrition ROC (Joel Greenblatt) % Related Terms


Cellev8 Nutrition ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Cellev8 Nutrition's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellev8 Nutrition ROC (Joel Greenblatt) % Chart

Cellev8 Nutrition Annual Data
Trend Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial 0.00 0.00 0.00 -11,586.67 -9,706.25

Cellev8 Nutrition Semi-Annual Data
Nov07 Nov08 Nov09 Nov10 Nov14 Nov15
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 0.00 0.00 0.00 -11,586.67 -9,706.25

CELV vs LFVN, MAMA, NATR: ROC (Joel Greenblatt) % Comparison

For the Packaged Foods subindustry, Cellev8 Nutrition's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellev8 Nutrition ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cellev8 Nutrition's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Cellev8 Nutrition's ROC (Joel Greenblatt) % falls into.


CELV
30GF Score
Cellev8 Nutrition Inc CELV
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellev8 Nutrition ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Nov. 2014 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.352 + 0) - (4.569 + 0 + 0)
=-4.217

Working Capital(Q: Nov. 2015 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.043 + 0.391 + 0) - (5.412 + 0.022 + -0.0010000000000012)
=-4.999

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Cellev8 Nutrition for the quarter that ended in Nov. 2015 can be restated as:

ROC (Joel Greenblatt) %(Q: Nov. 2015 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2014  Q: Nov. 2015
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.553/( ( (0.015 + max(-4.217, 0)) + (0.017 + max(-4.999, 0)) )/ 2 )
=-1.553/( ( 0.015 + 0.017 )/ 2 )
=-1.553/0.016
=-9,706.25 %

Note: The EBIT data used here is one times the annual (Nov. 2015) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -9,706.25% mean?
Cellev8 Nutrition (CELV) has a ROC (Joel Greenblatt) % of -9,706.25% as of Nov. 2015. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Cellev8 Nutrition and its competitors.
Is Cellev8 Nutrition's ROC (Joel Greenblatt) % too high?
Cellev8 Nutrition's current ROC (Joel Greenblatt) % is -9,706.25%. Overall, Cellev8 Nutrition has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cellev8 Nutrition's ROC (Joel Greenblatt) % compare to LFVN and MAMA?
Cellev8 Nutrition's ROC (Joel Greenblatt) % of -9,706.25% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROC (Joel Greenblatt) % is 11.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 11.99, based on 1,978 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Cellev8 Nutrition and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellev8 Nutrition's current ROC (Joel Greenblatt) % is -9,706.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellev8 Nutrition stock overvalued right now?
Cellev8 Nutrition (CELV) has a current ROC (Joel Greenblatt) % of -9,706.25%. The current ROC (Joel Greenblatt) % is -9,706.25%. Cellev8 Nutrition's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Cellev8 Nutrition (CELV), the current ROC (Joel Greenblatt) % is -9,706.25% as of Nov. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellev8 Nutrition Business Description

Address 3361 Fairline Farms Road, Unit No. 3, Wellington, FL, USA, 33414
Cellev8 Nutrition Inc is engaged in the development, markets, and sells a line of proprietary blended cellular therapeutics named Cellev8. Its products are based on formulations containing Superoxide Dismutase (SOD) and are developed for health-related applications.
30GF Score

Get the complete analysis for CELV

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price